Rating Change
HC Wainwright & Co. reiterated its Buy rating on Kodiak Sciences Inc. (NASDAQ:KOD) on August 17, 2026.
HC Wainwright & Co. reiterated its Buy rating on Kodiak Sciences Inc.

At publication ·
Kodiak Sciences Inc. (NASDAQ:KOD) · reiterate
At a glance
HC Wainwright & Co. reiterated its Buy rating on Kodiak Sciences Inc. (NASDAQ:KOD) on August 17, 2026.
Kodiak Sciences Inc. operates in the Healthcare sector. The stock currently trades at $41.55 with a market capitalization of $1.3B. The stock has gained 379.7% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Kodiak Sciences Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 17, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 03, 2026 | JP Morgan | Overweight | N/A |
| May 11, 2026 | Chardan Capital | Buy | N/A |
| Mar 27, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 27, 2026 | UBS | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View KOD Stock Page
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Kodiak Sciences Inc. (NASDAQ:KOD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the KOD forecast page.
Current market data
NASDAQ · KOD
Keep reading